FRAXODI Side Effects

5161747-5 | Blood Alkaline Phosphatase Increased, Cholestasis, Mixed Hepatocellular-cholestatic Injury, Transaminases Increased
on Nov 20, 2006 Male patient from FRANCE , 56 years of age, weighting 172.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Fraxodi (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, cholestasis, mixed hepatocellular-cholestatic injury, transaminases increased. Fraxodi dosage: .7ml Per Day. During the same period patient was treated with NICORETTE (1unit Per Day) (View Nicorette Review and Nicorette Label ), NEXIUM (20mg At Night) (View Nexium Review and Nexium Label ), EFFERALGAN CODEINE (2unit Three Times Per Day) (View Efferalgan Codeine Review and Efferalgan Codeine Label ), PREVISCAN (20mg At Night) (View Previscan Review and Previscan Label ), SOLUPRED (60mg In The Morning) (View Solupred Review and Solupred Label ), ATARAX (100mg Per Day) (View Atarax Review and Atarax Label ). Patient was hospitalized.

5045205-4 | Anaemia, Cervix Disorder, Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Hyponatraemia, Melaena, Pulmonary Embolism, Renal Infarct, Urine Output Decreased
Patient was taking Fraxodi (View Usage). Patient had the following side effects: anaemia, cervix disorder, deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, hyponatraemia, melaena, pulmonary embolism (What is pulmonary embolism?), renal infarct, urine output decreased on Mar 24, 2006 from FRANCE Additional patient health information: Female patient , 84 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), thrombosis prophylaxis, hypertension and. Fraxodi dosage: .6ml Per Day. During the same period patient was treated with ARIXTRA (2.5mg Per Day) (View Arixtra Review and Arixtra Label ), LOVENOX (40mg Per Day) (View Lovenox Review and Lovenox Label ), DIGOXIN (1unit Per Day) (View Digoxin Review and Digoxin Label ), MANIDIPINE (1tab At Night) (View Manidipine Review and Manidipine Label ), COKENZEN (1tab In The Morning) (View Cokenzen Review and Cokenzen Label ), CELEBREX (View Celebrex Review and Celebrex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

4966022-7 | Anaemia, Cervix Disorder, Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Hyponatraemia, Melaena, Pulmonary Embolism, Renal Infarct, Urine Output Decreased
Adverse event was reported on Mar 24, 2006 by a Female patient taking Fraxodi (View Usage) (Dosage: .6ml Per Day) . Location: FRANCE , 84 years of age, After Fraxodi was administered, patient had the following side effects: anaemia, cervix disorder, deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, hyponatraemia, melaena, pulmonary embolism (What is pulmonary embolism?), renal infarct, urine output decreased. During the same period patient was treated with ARIXTRA (2.5mg Per Day) (View Arixtra Review and Arixtra Label ), LOVENOX (40mg Per Day) (View Lovenox Review and Lovenox Label ), DIGOXIN (1unit Per Day) (View Digoxin Review and Digoxin Label ), MANIDIPINE (1tab At Night) (View Manidipine Review and Manidipine Label ), COKENZEN (1tab In The Morning) (View Cokenzen Review and Cokenzen Label ), CELEBREX (View Celebrex Review and Celebrex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

4958248-3 | Anaemia, Cervix Disorder, Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Hyponatraemia, Melaena, Pulmonary Embolism, Renal Infarct, Urine Output Decreased
on Mar 24, 2006 Female patient from FRANCE , 84 years of age, was treated with Fraxodi (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cervix disorder, deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, hyponatraemia, melaena, pulmonary embolism (What is pulmonary embolism?), renal infarct, urine output decreased. Fraxodi dosage: .6ml Per Day. During the same period patient was treated with ARIXTRA (2.5mg Per Day) (View Arixtra Review and Arixtra Label ), SECTRAL (200mg Twice Per Day) (View Sectral Review and Sectral Label ), DIGOXIN (1unit Per Day) (View Digoxin Review and Digoxin Label ), MANIDIPINE (1tab At Night) (View Manidipine Review and Manidipine Label ), COKENZEN (1tab In The Morning) (View Cokenzen Review and Cokenzen Label ), CELEBREX (View Celebrex Review and Celebrex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.